Literature DB >> 29379

Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.

J Dreyfuss, J M Shaw, J J Ross.   

Abstract

1. Dogs absorbed [14C]nadolol almost completely (88--104%) after oral administration of 10--75 mg/kg. In contrast, mice, rats, hamsters, and rabbits, given oral doses of 20 mg/kg, absorbed, at most, 25%. After administration of oral doses of 2--75 mg/kg, monkeys absorbed no more than an average of 30%. Six monkeys given oral doses of 10 mg/kg absorbed 12--44%. 2. In rats, [14C]nadolol was orally absorbed to an average of 13.7--17.5%, whether given in suspension or in solution, indicating that absorption was not limited by rate of dissolution nor by solubility. 3. Mildly hypertensive humans given single doses of [14C]nadolol (2 or 80 mg, orally) and normal subjects given single doses (10 mg, orally) absorbed an average of 20.4--33.3%.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29379     DOI: 10.3109/00498257809056152

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats.

Authors:  Safiyya Zaidi; Fatin Atrooz; Daniel Valdez; Hesong Liu; Camila Kochi; Richard A Bond; Samina Salim
Journal:  Neurosci Lett       Date:  2020-03-09       Impact factor: 3.046

2.  Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.

Authors:  Marc-Etienne Castella; Marianne Reist; Joachim M Mayer; Jean-Jacques Turban; Bernard Testa; Claire Boursier-Neyret; Bernard Walther; Jean-Marie Delbos; Pierre-Alain Carrupt
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

3.  Pharmacokinetics of nadolol in healthy subjects.

Authors:  M Schäfer-Korting; N Bach; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.

Authors:  W L Chiou; H Y Jeong; S M Chung; T C Wu
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

Review 5.  Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

6.  Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.

Authors:  P J Cadigan; D R London; B L Pentecost; G Bianchetti; R Gomeni; J R Kilborn; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.